Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cytokinetics

37.66
-0.6830-1.78%
Volume:799.45K
Turnover:30.55M
Market Cap:4.51B
PE:-7.36
High:39.12
Open:38.37
Low:37.58
Close:38.34
52wk High:59.39
52wk Low:29.31
Shares:119.66M
Float Shares:119.09M
Volume Ratio:0.66
T/O Rate:0.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.1182
EPS(LYR):-5.2646
ROE:-572.15%
ROA:-24.87%
PB:-12.22
PE(LYR):-7.15

Loading ...

Aug 20, 2025

Major Issues Report

Form 8-K - Current report
Aug 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Jul 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Major Issues Report

Form 8-K - Current report
May 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2025

Major Issues Report

Form 8-K - Current report
May 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2025

Major Issues Report

Form 8-K - Current report
Apr 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 10, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities